InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RUB | Ann: Update - Delayed Half Year 2019 Financial Statements | 12/03/19 | 0 | 349 | |||
|
|||||||
RUB | Ann: Suspension from Official Quotation | 07/03/19 | 3 | 1.2K | |||
|
|||||||
RUB | Ann: Delayed Half Year 2019 Financial Statements | 01/03/19 | 0 | 96 | |||
|
|||||||
RUB | Ann: Final share buy-back notice - Appendix 3F | 20/12/18 | 0 | 288 | |||
|
|||||||
RUB | Ann: Results of 2018 Annual General Meeting | 30/11/18 | 0 | 117 | |||
|
|||||||
RUB | News: RUB Rubicor Group Says Co Believe Group's Businesses Will Grow Assets & Profitability In... | 30/11/18 | 0 | 241 | |||
|
|||||||
RUB | News: RUB Rubicor Group Says Sharad Loomba Appointed CEO | 30/11/18 | 0 | 97 | |||
|
|||||||
RUB | Ann: AGM CEO Presentation | 30/11/18 | 0 | 122 | |||
|
See All Discussions